科兴生物(SVA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SVA 科兴生物

停牌 12-15 09:07:06 EST

6.47

+0.00

0.00%

最高6.47	最低6.47	成交量0.00
今开6.47	昨收6.47	日振幅0.00%
总市值3.89亿	流通市值2.02亿	总股本6,006万
成交额0.00	换手率0.00%	流通股本3,117万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SVA","market":"US","secType":"STK","nameCN":"科兴生物","latestPrice":6.47,"timestamp":1765573200000,"preClose":6.47,"halted":3,"volume":0,"delay":0,"floatShares":31169000,"shares":60060702,"eps":0.971025,"marketStatus":"停牌","change":0,"latestTime":"12-15 09:07:06 EST","open":6.47,"high":6.47,"low":6.47,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.971025,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765809000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1102482000000,"exchange":"NASDAQ","adjPreClose":6.47,"volumeRatio":0.5219117885997689},"requestUrl":"/m/hq/s/SVA","defaultTab":"news","newsList":[{"id":"2586204858","title":"科兴生物陷退市危机，十年内斗拖累经营与治理","url":"https://stock-news.laohu8.com/highlight/detail?id=2586204858","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586204858?lang=zh_cn&edition=full","pubTime":"2025-11-28 15:51","pubTimestamp":1764316260,"startTime":"0","endTime":"0","summary":"11月19日，科兴生物公告称收到纳斯达克上市资格部门的退市决定函，原因在于公司未能在2025年11月11日前提交2024年年度报告。尽管公司已表示将提交听证申请以暂缓退市，但这一事件再次暴露了其长期存在的公司治理问题。　　审计机构致同会计师事务所于2025年4月辞任，直接导致年报无法按时提交。　　科兴生物的退市危机，表面上是审计机构变更与年报延迟所致，实则是长期公司治理混乱、控制权争夺与经营战略失衡的集中爆发。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2025-11-28/doc-infyxwfh7408453.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2585779891","title":"科兴生物再触退市红线 治理困局拖累美股上市地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2585779891","media":"华夏时报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585779891?lang=zh_cn&edition=full","pubTime":"2025-11-22 22:22","pubTimestamp":1763821375,"startTime":"0","endTime":"0","summary":"纳斯达克的一纸退市函，对已停牌六年的科兴生物下达了最后通牒，其美股上市地位命悬一线。因未按期提交2024年年度报告，科兴生物（NASDAQ：SVA）于2025年11月12日收到纳斯达克上市资格部门的退市决定函。若未能在规定时间内申请听证，公司股票将于11月21日起暂停交易并启动退市程序。这是自2019年因治理问题被停牌后，科兴生物面临的第二次退市危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511223572077338.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511223572077338.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2584722409","title":"科兴生物收到纳斯达克退市通知；广誉远副总裁离任","url":"https://stock-news.laohu8.com/highlight/detail?id=2584722409","media":"21世纪经济报道","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584722409?lang=zh_cn&edition=full","pubTime":"2025-11-20 08:06","pubTimestamp":1763597181,"startTime":"0","endTime":"0","summary":"政策动向黄果在北京调研集采中选药品质量监管工作11月18日，国家药监局党组成员、副局长黄果在北京市调研集采中选药品质量监管工作，实地走访华润双鹤药业股份有限公司，调研企业质量管理及地方药品监管部门监管情况。黄果指出，国家药监局高度重视集采药品的质量监管，在各方持续努力下，生产供应质量整体稳定可控。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511203569355255.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511203569355255.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["MNQmain","ARTL","QID","QLD","TSYW.SI",".IXIC","NQmain","USJW.SI","BK1147","03086","NVIW.SI","USAW.SI","BK4139","PSQ","SVA","TQQQ","SQQQ","BK4007"],"gpt_icon":1},{"id":"2584717948","title":"科兴生物收到纳斯达克退市通知 公司回应：计划进行听证申辩会","url":"https://stock-news.laohu8.com/highlight/detail?id=2584717948","media":"每日经济新闻","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584717948?lang=zh_cn&edition=full","pubTime":"2025-11-19 19:26","pubTimestamp":1763551600,"startTime":"0","endTime":"0","summary":"科兴生物更新了一则关于纳斯达克退市事项的进展。公司披露的信息显示，其于2025年11月12日收到纳斯达克股票市场有限责任公司（即“纳斯达克”）上市资格部发出的退市决定函。此决定是由于公司未能遵守纳斯达克上市规则5250(c)(1)，未能在延长期限前及时提交截至2024年12月31日财年的年度报告。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511193568947938.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511193568947938.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SVA","PSQ","USAW.SI","NQmain","TSYW.SI","TQQQ","ARTL","BK1147","BK4139",".IXIC","NVIW.SI","QLD","SQQQ","BK4007","MNQmain","QID","USJW.SI","03086"],"gpt_icon":0},{"id":"2582242993","title":"科兴生物冲刺港股：上半年营收7亿，同比降7.9% 利润7896万","url":"https://stock-news.laohu8.com/highlight/detail?id=2582242993","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582242993?lang=zh_cn&edition=full","pubTime":"2025-11-12 17:58","pubTimestamp":1762941485,"startTime":"0","endTime":"0","summary":"科兴生物制药股份有限公司（简称：“科兴生物”）日前递交招股书，准备在港交所上市。招股书显示，科兴生物2022年、2023年、2024年营收分别为13.16亿元、12.59亿元、14亿元；","market":"us","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20251112/6389856707018815885006308.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20251112/6389856707018815885006308.jpeg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n31745/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["SVA"],"gpt_icon":0},{"id":"2555883641","title":"科兴甲型乙型肝炎联合疫苗倍尔来福再注册上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2555883641","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555883641?lang=zh_cn&edition=full","pubTime":"2025-07-31 17:36","pubTimestamp":1753954618,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2553206188","title":"知情人士：解决科兴“内斗”应以谈为主 科兴生物董事长李嘉强称尹卫东是个好CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2553206188","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553206188?lang=zh_cn&edition=full","pubTime":"2025-07-24 17:53","pubTimestamp":1753350790,"startTime":"0","endTime":"0","summary":"谈及科兴创始人之一的尹卫东，上述知情人士称，李嘉强与其已认识十五年。据了解，中间打官司的这些年，两人也有见面，围绕科兴的治理问题，双方所代表的董事会有利益冲突，也有过一些误解，但李嘉强还是认为“尹卫东是一个很好的CEO”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072417550494b8039a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072417550494b8039a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2551126212","title":"科兴“宫斗”背后，第一大股东强新资本的算盘","url":"https://stock-news.laohu8.com/highlight/detail?id=2551126212","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551126212?lang=zh_cn&edition=full","pubTime":"2025-07-16 21:59","pubTimestamp":1752674397,"startTime":"0","endTime":"0","summary":"目前，李嘉强控制的强新资本与关联公司持有科兴生物约三分之一的股份，是科兴生物的第一大股东。接近此事件的人士表示，他希望终结这场“宫斗”的一个重要的原因，是为了转移精力，推动强新科技原创药的研发上市。目前尚不清楚强新科技未来是否会寻求新的资本。2022年，潘爱华入狱，李嘉强正式踏入科兴股权争夺的中心。目前，双方的争议仍在持续中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507162200499544f1a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507162200499544f1a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2551125501","title":"科兴生物内斗漩涡：九年纷争何时落幕？又将走向何方？","url":"https://stock-news.laohu8.com/highlight/detail?id=2551125501","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551125501?lang=zh_cn&edition=full","pubTime":"2025-07-16 20:59","pubTimestamp":1752670759,"startTime":"0","endTime":"0","summary":"另据上述知情人士透露，科兴生物小股东部分的分红已基本到账；大股东及争议股份对应款项暂存共管账户。市场对于强新资本方增持科兴生物的目的以及合法性争议。在2016年3月，科兴生物宣布其通过了“毒丸计划”。然而，2025年4月22日，科兴生物管理层发表声明称，目前董事会与英国枢密院裁决确认的名单并不相符。值得注意的是，科兴生物于2019年2月22日宣布，收到纳斯达克发出的暂停交易通知。自此以来，科兴生物已经停牌超过6年之久。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716210300a44ed16b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716210300a44ed16b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2550987149","title":"一周医药速览（07.07-07.11）","url":"https://stock-news.laohu8.com/highlight/detail?id=2550987149","media":"财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550987149?lang=zh_cn&edition=full","pubTime":"2025-07-11 16:27","pubTimestamp":1752222452,"startTime":"0","endTime":"0","summary":"目前，市场上可用于小儿便秘的同类产品主要用于其他疾病伴发的便秘症状，临床尚无治疗小儿便秘的儿童专用中药创新药。甘李药业：预计上半年净利润增加100.73%到114.12%，胰岛素量价齐升甘李药业发布2025年半年度业绩预增公告。披露经财务部门初步测算，预计 2025 年半年度实现归属净利润为6亿元到6.4亿元，与上年同期相比，同比增加 100.73%到 114.12%。临床前多种动物模型研究结果显示，UBT37034与GLP-1类似物联用能显著降低体重。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711162815a44457d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711162815a44457d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","03933","SVA","06855","603087","01801","600566"],"gpt_icon":0},{"id":"2550619534","title":"科兴生物商业版图盘点","url":"https://stock-news.laohu8.com/highlight/detail?id=2550619534","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550619534?lang=zh_cn&edition=full","pubTime":"2025-07-10 15:21","pubTimestamp":1752132087,"startTime":"0","endTime":"0","summary":"天眼查App显示，科兴生物关联公司北京科兴生物制品有限公司成立于2001年4月，法定代表人为尹卫东，注册资本约1.41亿人民币，经营范围含药品生产、药品批发、药品进出口、医学研究和试验发展、货物进出口等。司法案件信息显示，该公司涉及多起案件，包括股东知情权纠纷、公司决议纠纷、医疗损害责任纠纷等。商业履历信息显示，科兴生物董事长尹卫东名下关联20余家企业，其中18家为存续状态，包括北京科兴益道医药有限公司、北京兴益鼎生物技术有限公司、科兴中维（海南）生物技术有限公司等，尹卫东在上述公司担任执行董事、法定代表人等。（责任编辑：刘静 HZ010）","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710153612a441fc50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710153612a441fc50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2550074618","title":"10位新董事上任，科兴生物特别股东大会通过赛富议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2550074618","media":"广州日报","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550074618?lang=zh_cn&edition=full","pubTime":"2025-07-10 14:41","pubTimestamp":1752129708,"startTime":"0","endTime":"0","summary":"7月9日，SAIFPartners（赛富投资基金）公告称，在科兴控股生物技术有限公司（简称“科兴生物”）特别股东大会上，股东投票通过了SAIFPartners提出的两项议案：罢免该公司现任董事，并选举SAIFPartners提名的10位资深董事候选人进入公司董事会。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202507103453279939.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2550801661","title":"科兴生物特别股东大会选举10位新董事；多家医药上市公司发半年度预增公告 | 医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2550801661","media":"每日经济新闻","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550801661?lang=zh_cn&edition=full","pubTime":"2025-07-10 07:21","pubTimestamp":1752103281,"startTime":"0","endTime":"0","summary":"丨2025年7月10日星期四丨NO.1甘李药业2025年半年度净利润预计翻番7月9日，甘李药业发布2025年半年度业绩预增公告，预计2025年半年度实现归母净利润6亿元到6.4亿元，同比增加100.73%到114.12%。公司表示主要受益于营业收入显著提升及费用的精细化管控。通过两轮胰岛素集采，公司成功实现扩大市场份额的战略目标。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202507103452616428.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202507103452616428.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09939","SVA","BK4139","BK1515","BK1574","BK1161"],"gpt_icon":0},{"id":"2550500529","title":"科兴生物股权争夺最新进展：特别股东会投票罢免现任董事，改选赛富基金提名董事进入董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=2550500529","media":"界面","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550500529?lang=zh_cn&edition=full","pubTime":"2025-07-09 14:05","pubTimestamp":1752041120,"startTime":"0","endTime":"0","summary":"7月9日，据赛富基金最新披露，在今早进行的科兴生物特别股东大会上，投票通过了赛富基金提出的两项提案：罢免公司现任董事，并选举由赛富提名的十位具备高度资质的董事候选人进入公司董事会。会议上，先由科兴生物现任董事长李嘉强主持召开特别会议，但随即宣布会议中止，并未给予股东参与表决的机会。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709140520a43f9677&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709140520a43f9677&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2550840578","title":"两大权威公司治理研究机构支持科兴生物现任董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=2550840578","media":"南方财富网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550840578?lang=zh_cn&edition=full","pubTime":"2025-07-08 19:13","pubTimestamp":1751973180,"startTime":"0","endTime":"0","summary":"随着科兴生物的控股股东特别股东大会临近，国际知名公司治理研究与股东投票咨询和代理机构Institutional Shareholder Services Inc.与 Glass Lewis，于上周先后发布分析报告，一致建议科兴股东支持由李嘉强博士领导的现任董事会。也释放出一个清晰信号：专业机构普遍认为，维持科兴生物控股的现有董事会，有助于保障股东权益、推动公司恢复正常运作。这项分红举措获得两大机构一致认可，Glass Lewis评价现任董事会“在恢复治理稳定和运营正常化方面取得了可信的进展”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709033641953b35b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709033641953b35b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2549815615","title":"科兴生物计划进行总额最高约75亿美元“清仓式分红”","url":"https://stock-news.laohu8.com/highlight/detail?id=2549815615","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549815615?lang=zh_cn&edition=full","pubTime":"2025-07-07 16:38","pubTimestamp":1751877531,"startTime":"0","endTime":"0","summary":"截至2024年6月，科兴生物现金储备约103亿美元，而三次分红总额约占现金的73%，故被市场称为“清仓式分红”。科兴生物还在公告中喊话，股东投票关系到能否如期获得补偿性股息。经香港高等法院于6月27日紧急聆讯，法庭拒绝授予其在传票所申请的任何救济措施。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1751876526133691941","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2503545080","title":"【科兴独家中标智利流感疫苗项目 首批疫苗将于明日发往智利】SINOVAC科兴中标智利项目新闻发布会上，科兴副总裁、国际业务负责人孟伟宁介绍，1月10号，SINOVAC科兴旗下北京科兴生物制品有限公司生产的三价流感疫苗安尔来福®独家中标了智利政府2025年年度流感疫苗的全球招标，首批疫苗将于1月15日发往智利。","url":"https://stock-news.laohu8.com/highlight/detail?id=2503545080","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503545080?lang=zh_cn&edition=full","pubTime":"2025-01-14 16:59","pubTimestamp":1736845176,"startTime":"0","endTime":"0","summary":"SINOVAC科兴中标智利项目新闻发布会上，科兴副总裁、国际业务负责人孟伟宁介绍，1月10号，SINOVAC科兴旗下北京科兴生物制品有限公司生产的三价流感疫苗安尔来福®独家中标了智利政府2025年年度流感疫苗的全球招标，首批疫苗将于1月15日发往智利。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/14165947435781.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["SVA","159646","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinovac.com;www.sinovac.com.cn","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"科兴控股生物技术有限公司于1999年3月1日在安提瓜和巴布达注册成立，是一家总部位于北京的生物高新技术企业。公司主要从事于研究，开发，制造及保护免受感染性疾病的疫苗。公司还曾先后研制出全球第一支SARS冠状病毒灭活疫苗（完成I期临床研究）、中国第一支大流行流感（H5N1）疫苗以及全球第一支甲型H1N1流感疫苗，为中国乃至全球疾病预防控制做出了贡献。公司正在开发一系列新产品，包括Sabin株脊髓灰质炎灭活疫苗、23价肺炎球菌多糖疫苗、新型冠状病毒灭活疫苗及多个联合疫苗等。","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":-0.027083},{"month":2,"riseRate":0.7,"avgChangeRate":0.044011},{"month":3,"riseRate":0.777778,"avgChangeRate":0.016157},{"month":4,"riseRate":0.111111,"avgChangeRate":-0.050461},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.034293},{"month":6,"riseRate":0.444444,"avgChangeRate":0.023452},{"month":7,"riseRate":0.222222,"avgChangeRate":-0.027021},{"month":8,"riseRate":0.444444,"avgChangeRate":0.025862},{"month":9,"riseRate":0.666667,"avgChangeRate":0.007361},{"month":10,"riseRate":0.666667,"avgChangeRate":0.018455},{"month":11,"riseRate":0.666667,"avgChangeRate":0.055242},{"month":12,"riseRate":0.272727,"avgChangeRate":-0.009096}],"exchange":"NASDAQ","name":"科兴生物","nameEN":"Sinovac Biotech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科兴生物(SVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科兴生物(SVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科兴生物,SVA,科兴生物股票,科兴生物股票老虎,科兴生物股票老虎国际,科兴生物行情,科兴生物股票行情,科兴生物股价,科兴生物股市,科兴生物股票价格,科兴生物股票交易,科兴生物股票购买,科兴生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科兴生物(SVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科兴生物(SVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}